The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Open accessAbstract
The IGF system plays critical roles in somatic growth in an endocrine fashion (somatomedin hypothesis) as well as proliferation and differentiation of normal and malignant cells in a paracrine/autocrine fashion. IGFBP-3 is known to modulate the actions of IGFs in circulation as well as the immediate extracellular environment. Interestingly, apart from the ability to inhibit or enhance IGF actions, IGFBP-3 also exhibits very clear, distinct biological effects independent of the IGF/IGF-I receptor axis. Over the past decade it has become widely appreciated that IGF/IGF-IR-independent actions of IGFBP-3 (antiproliferative and proapoptotic effects) contribute to improving the pathophysiology of a variety of human diseases, such as cancer, diabetes, and malnutrition. Recent studies have implicated interaction of IGFBP-3 with a variety of proteins or signaling cascades critical to cell cycle control and apoptosis; however, the actual mechanism of IGFBP-3 action is still unclear. This review reinforces the concept in support of the IGF/IGF-IR axis-independent actions of IGFBP-3 and delineates potential underlying mechanisms involved and subsequent biological significance, focusing in particular on functional binding partners and the clinical significance of IGFBP-3 in the assessment of cancer risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J.-L., Stannard, B., Butler, A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,420
Processing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
Interaction between Oct3/4 and Cdx2 Determines Trophectoderm Differentiation
Niwa, H., Toyooka, Y., Shimosato, D., Strumpf, D., Takahashi, K., Yagi, R., & Rossant, J. (2005) · Cell · doi:10.1016/j.cell.2005.08.040 · Cited by 1,190
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Rajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
Caspases in apoptosis and beyond
Li, J., & Yuan, J. (2008) · Oncogene · doi:10.1038/onc.2008.297 · Cited by 1,090
The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*
Hwa, V., Oh, Y., & Rosenfeld, R. G. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0382 · Cited by 1,079
Self-citationProteolytic remodeling of extracellular matrix
Birkedal-Hansen, H. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80116-2 · Cited by 1,074
Principles of Tumor Suppression
Sherr, C. J. (2004) · Cell · doi:10.1016/s0092-8674(03)01075-4 · Cited by 1,034
Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life?
Kastner, P., Mark, M., & Chambon, P. (1995) · Cell · doi:10.1016/0092-8674(95)90202-3 · Cited by 995
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Sjögren, K., Liu, J.-L., Blad, K., Skrtic, S., Vidal, O., Wallenius, V., LeRoith, D., Törnell, J., Isaksson, O. G. P., Jansson, J.-O., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7088 · Cited by 938
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
Baylin, S. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.687 · Cited by 929
Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
Lagna, G., Hata, A., Hemmati-Brivanlou, A., & Massagué, J. (1996) · Nature · doi:10.1038/383832a0 · Cited by 905
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
Stewart, C. E., & Rotwein, P. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.4.1005 · Cited by 776
Rajah, R., Valentinis, B., & Cohen, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12181 · Cited by 722
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Cytochrome c Release and Apoptosis Induced by Mitochondrial Targeting of Nuclear Orphan Receptor TR3
Li, H., Kolluri, S. K., Gu, J., Dawson, M. I., Cao, X., Hobbs, P. D., Lin, B., Chen, G.-Q., Lu, J.-S., Lin, F., et al. (2000) · Science · doi:10.1126/science.289.5482.1159 · Cited by 667
The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation
Karin, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27339 · Cited by 640
Fraser, A., & Evan, G. (1996) · Cell · doi:10.1016/s0092-8674(00)81005-3 · Cited by 638
Unique response pathways are established by allosteric interactions among nuclear hormone receptors
Forman, B. M., Umesono, K., Chen, J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90075-6 · Cited by 624
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
Hazel, T. G., Nathans, D., & Lau, L. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.22.8444 · Cited by 515
Cohen, P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1046 · Cited by 497
Oh, Y., Müller, H. L., Lamson, G., & Rosenfeld, R. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82426-7 · Cited by 472
Self-citationYu, W.-H., Woessner, J. F., McNeish, J. D., & Stamenkovic, I. (2002) · Genes & Development · doi:10.1101/gad.925702 · Cited by 471
Plasmin and Matrix Metalloproteinases in Vascular Remodeling
Lijnen, H. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616230 · Cited by 453
Prieur, A., Tirode, F., Cohen, P., & Delattre, O. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7275-7283.2004 · Cited by 420
Matrix metalloproteinases in tumor–host cell communication
Lynch, C. C., & Matrisian, L. M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700909.x · Cited by 386
Butler, A. A., & Roith, D. L. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.141 · Cited by 385
Serum insulin-like growth factor-I and breast cancer
Toniolo, P., Bruning, P. F., Akhmedkhanov, A., Bonfrer, J. M. G., Koenig, K. L., Lukanova, A., Shore, R. E., & Zeleniuch-Jacquotte, A. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001201)88:5<828::aid-ijc22>3.0.co;2-8 · Cited by 341
Hashimoto, G., Inoki, I., Fujii, Y., Aoki, T., Ikeda, E., & Okada, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201674200 · Cited by 339
Roddam, A., Allen, N. E., Appleby, P. N., Key, T. J., Ferrucci, L., Carter, H. B., Metter, E. J., Chen, C., Weiss, N. S., Fitzpatrick, A. L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-7-200810070-00006 · Cited by 331
Liu, B., Lee, H.-Y., Weinzimer, S. A., Powell, D. R., Clifford, J. L., Kurie, J. M., & Cohen, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002547200 · Cited by 326
Harrela, M., Koistinen, H., Kaprio, J., Lehtovirta, M., Tuomilehto, J., Eriksson, J., Toivanen, L., Koskenvuo, M., Leinonen, P., Koistinen, R., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119081 · Cited by 323
Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen
Palayoor, S. T., Youmell, M. Y., Calderwood, S. K., Coleman, C. N., & Price, B. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203160 · Cited by 317
Oh, Y., Müller, H. L., Pham, H., & Rosenfeld, R. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74273-2 · Cited by 313
Self-citationGiri, D. K., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.14008 · Cited by 299
Targeting Apoptosis Pathways in Cancer Therapy
Fulda, S., & Debatin, K.-M. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332763 · Cited by 290
Schedlich, L. J., Le Page, S. L., Firth, S. M., Briggs, L. J., Jans, D. A., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002208200 · Cited by 280
Ikonen, M., Liu, B., Hashimoto, Y., Ma, L., Lee, K.-W., Niikura, T., Nishimoto, I., & Cohen, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135111100 · Cited by 279
Schedlich, L. J., Young, T. F., Firth, S. M., & Baxter, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18347 · Cited by 272
Cohen, P., Peehl, D. M., Graves, H. C. B., & Rosenfeld, R. G. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1420407 · Cited by 268
Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
Byrne, C., Colditz, G. A., Willett, W. C., Speizer, F. E., Pollak, M., & Hankinson, S. E. (2000) · PubMed · Cited by 256
Leal, S. M., Liu, Q., Huang, S. S., & Huang, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20572 · Cited by 255
Yamashita, S., Tsujino, Y., Moriguchi, K., Tatematsu, M., & Ushijima, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00136.x · Cited by 253
Gucev, Z. S., Oh, Y., Kelley, K. M., & Rosenfeld, R. G. (1996) · PubMed · Cited by 253
Self-citationThe Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Belfiore, A. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780249173 · Cited by 252
Rowlands, M., Gunnell, D., Harris, R., Vatten, L. J., Holly, J. M. P., & Martin, R. M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24202 · Cited by 251
Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors
Dijke, P. T., Miyazono, K., & Heldin, C.-H. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80058-5 · Cited by 250
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis
Zhu, W., Shiojima, I., Ito, Y., Li, Z., Ikeda, H., Yoshida, M., Naito, A. T., Nishi, J.-I., Ueno, H., Umezawa, A., et al. (2008) · Nature · doi:10.1038/nature07027 · Cited by 241
Oh, Y., Müller, H. L., Ng, L., & Rosenfeld, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13589 · Cited by 237
Self-citationWolpin, B. M., Meyerhardt, J. A., Chan, A. T., Ng, K., Chan, J. A., Wu, K., Pollak, M. N., Giovannucci, E. L., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9945 · Cited by 231
Negative controls of cell proliferation: human prostate cancer cells and androgens.
Sonnenschein, C., Olea, N., Pasanen, M. E., & Soto, A. M. (1989) · PubMed · Cited by 224
Huynh, H., Yang, X., & Pollak, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1016 · Cited by 219
Butt, A. J., Firth, S. M., King, M. A., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908888199 · Cited by 214
Deal, C., Ma, J., Wilkin, F., Paquette, J., Rozen, F., Ge, B., Hudson, T., Stampfer, M., & Pollak, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7280 · Cited by 206
Wu, R.-Y., Zhang, Y., Feng, X.-H., & Derynck, R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2521 · Cited by 205
Kaaks, R., Lundin, E., Manjer, J., Rinaldi, S., Biessy, C., Söderberg, S., Lenner, P., Janzon, L., Riboli, E., Berglund, G., et al. (2002) · Cancer Causes & Control · doi:10.1023/a:1015270324325 · Cited by 198
Lee, C. (1995) · Endocrinology · doi:10.1210/en.136.2.796 · Cited by 197
Tissue Transglutaminase Has Intrinsic Kinase Activity
Mishra, S., & Murphy, L. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311919200 · Cited by 186
Boyle, B. J., Zhao, X.-Y., Cohen, P., & Feldman, D. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(01)69892-6 · Cited by 186
Self-citationKalus, W. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6558 · Cited by 181
Lofqvist, C., Chen, J., Connor, K. M., Smith, A. C. H., Aderman, C. M., Liu, N., Pintar, J. E., Ludwig, T., Hellstrom, A., & Smith, L. E. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702031104 · Cited by 175
Lalou, C. (1996) · Endocrinology · doi:10.1210/en.137.8.3206 · Cited by 168
Type-2 IGF Receptor: A Multi-Ligand Binding Protein
Braulke, T. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978725 · Cited by 166
Cohen, P. (1993) · Molecular Endocrinology · doi:10.1210/me.7.3.380 · Cited by 165
Rinaldi, S., Peeters, P. H. M., Berrino, F., Dossus, L., Biessy, C., Olsen, A., Tjonneland, A., Overvad, K., Clavel-Chapelon, F., Boutron-Ruault, M. C., et al. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01150 · Cited by 164
Sitar, T., Popowicz, G. M., Siwanowicz, I., Huber, R., & Holak, T. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605652103 · Cited by 163
Cellular growth inhibition by IGFBP‐3 and TGF‐β 1 requires LRP‐1
Huang, S. S., Ling, T., Tseng, W.-F., Huang, Y.-H., Tang, F.-M., Leal, S. M., & Huang, J. S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0256com · Cited by 161
Siddle, K., Ursø, B., Niesler, C. U., Cope, D. L., Molina, L., Surinya, K. H., & Soos, M. A. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290513 · Cited by 158
Bourdon, J., Chambon, V., Lelong, J., Dessen, P., May, P., Debuire, B., & May, E. (1997) · Oncogene · doi:10.1038/sj.onc.1200804 · Cited by 156
Identification of Novel Target Genes by an Epigenetic Reactivation Screen of Renal Cancer
de Cáceres, I. I., Dulaimi, E., Hoffman, A. M., Al‐Saleem, T., Uzzo, R. G., & Cairns, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3365 · Cited by 154
Miyamoto, S., Yano, K., Sugimoto, S., Ishii, G., Hasebe, T., Endoh, Y., Kodama, K., Goya, M., Chiba, T., & Ochiai, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1916 · Cited by 154
Nuclear Localization of Insulin-Like Growth Factor Binding Protein 3 in a Lung Cancer Cell Line
Jaques, G., Noll, K., Wegmann, B., Witten, S., Kogan, E., Radulescu, R. T., & HAVEMANN, K. (1997) · Endocrinology · doi:10.1210/endo.138.4.5177 · Cited by 153
Novel Aspects of the Insulin-like Growth Factor Binding Proteins
Wetterau, L. A., Moore, M. G., Lee, K.-W., Shim, M. L., & Cohen, P. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2920 · Cited by 149
Peng, L., Malloy, P. J., & Feldman, D. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0344 · Cited by 147
Self-citationDeal, C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1274 · Cited by 146
Lee, K., Ma, L., Yan, X., Liu, B.-R., Zhang, X.-K., & Cohen, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412757200 · Cited by 144
Cellular Internalization of Insulin-like Growth Factor Binding Protein-3
Lee, K., Liu, B.-R., Ma, L., Li, H., Bang, P., Koeffler, H. P., & Cohen, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307316200 · Cited by 142
Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases
Fowlkes, J. L., Thrailkill, K. M., Serra, D. M., Suzuki, K., & Nagase, H. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00017-8 · Cited by 138
Fletcher, O., Gibson, L., Johnson, N., Altmann, D. R., Holly, J. M. P., Ashworth, A., Peto, J., & dos‐Santos‐Silva, I. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.2.14.1 · Cited by 138
Chang, Y. S., Wang, L., Liu, D., Mao, L., Hong, W. K., Khuri, F. R., & Lee, H. (2002) · PubMed · Cited by 136
Chang, K. H., Chan‐Ling, T., McFarland, E. L., Afzal, A., Pan, H., Baxter, L. C., Shaw, L. C., Caballero, S., Sengupta, N., Calzi, S. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702072104 · Cited by 135
Mitsui, Y., Mochizuki, S., Kodama, T., Shimoda, M., Ohtsuka, T., Shiomi, T., Chijiiwa, M., Ikeda, T., Kitajima, M., & Okada, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0377 · Cited by 133
Missmer, S. A., Spiegelman, D. L., Bertone‐Johnson, E. R., Barbieri, R. L., Pollak, M., & Hankinson, S. E. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0848 · Cited by 131
TR3/Nur77 in colon cancer cell apoptosis.
Wilson, A. J., Arango, D., Mariadason, J. M., Heerdt, B. G., & Augenlicht, L. H. (2003) · PubMed · Cited by 131
ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3
Mochizuki, S., Shimoda, M., Shiomi, T., Fujii, Y., & Okada, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.022 · Cited by 129
Li, W., Fawcett, J., Widmer, H. R., Fielder, P. J., Rabkin, R., & Keller, G.-A. (1997) · Endocrinology · doi:10.1210/endo.138.4.5176 · Cited by 128
Hanafusa, T., Yumoto, Y., Nouso, K., Nakatsukasa, H., Onishi, T., Fujikawa, T., 谷山真由美, Nakamura, S., Uemura, M., Takuma, Y., et al. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00736-4 · Cited by 126
Transferrin Is an Insulin-Like Growth Factor-Binding Protein-3 Binding Protein
WEINZIMER, S. A., Gibson, T. B., Collett‐Solberg, P. F., Khare, A., Liu, B.-R., & Cohen, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7380 · Cited by 125
1 ,25-Dihydroxyvitamin D3 Actions in LNCaP Human Prostate Cancer Cells Are Androgen-Dependent
Zhao, X.-Y., Ly, L. H., Peehl, D. M., & Feldman, D. (1997) · Endocrinology · doi:10.1210/endo.138.8.5328 · Cited by 125
Self-citationWu, Q. (2002) · Carcinogenesis · doi:10.1093/carcin/23.10.1583 · Cited by 124
Conover, C. A., & León, D. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37248-4 · Cited by 123
Imai, Y., Moralez, A., Andag, U., Clarke, J. B., Busby, W. H., & Clemmons, D. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000070200 · Cited by 123
Sadowski, T., Dietrich, S., Koschinsky, F., & Sedlacek, R. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-01-0009 · Cited by 120
Patel, A. V., Cheng, I. C., Canzian, F., Marchand, L. L., Thun, M. J., Berg, C. D., Buring, J. E., Calle, E. E., Chanock, S. J., Clavel‐Chapelon, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002578 · Cited by 118
Granata, R., Trovato, L., Garbarino, G. M., Taliano, M., Ponti, R., Sala, G., Ghidoni, R., & Ghigo, E. (2004) · The FASEB Journal · doi:10.1096/fj.04-1618fje · Cited by 118
Mortality and Serum Insulin-Like Growth Factor (IGF)-I and IGF Binding Protein 3 Concentrations
Friedrich, N., Haring, R., Nauck, M. A., Lüdemann, J., Rosskopf, D., Spilcke-Liss, E., Felix, S. B., Dörr, M., Brabant, G. E., Völzke, H., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2138 · Cited by 117
Firth, S., & Baxter, R. C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600379 · Cited by 116
Fanayan, S., Firth, S. M., Butt, A. J., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006964200 · Cited by 112
Keinan‐Boker, L., Bueno-de-Mesquita, H. B., Kaaks, R., van Gils, C. H., van Noord, P. A. H., Rinaldi, S., Ríboli, E., Seidell, J. C., Grobbee, D. E., & Peeters, P. H. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11193 · Cited by 107
Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer
Baglietto, L., English, D. R., Hopper, J. L., Morris, H. A., Tilley, W. D., & Giles, G. G. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0960 · Cited by 105
Kim, H.-S., Ingermann, A. R., Tsubaki, J., Twigg, S. M., Walker, G. E., & Oh, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1675 · Cited by 104
Self-citationLeal, S. M., Huang, S. S., & Huang, J. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6711 · Cited by 104
Perks, C. M., Newcomb, P. V., Norman, M., & Holly, J. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220141 · Cited by 103
Mode of Growth Hormone Action in Osteoblasts
DiGirolamo, D. J., Mukherjee, A., Fulzele, K. S., Gan, Y., Cao, X., Frank, S. J., & Clemens, T. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705219200 · Cited by 102
Insulin-like Growth Factor-binding Protein-3 Binds Fibrinogen and Fibrin
Campbell, P. G., Durham, S. K., Hayes, J. D., Suwanichkul, A., & Powell, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30215 · Cited by 101
Allen, N. E., Key, T. J., Appleby, P. N., Travis, R. C., Roddam, A., Rinaldi, S., Egevad, L., Rohrmann, S., Linseisen, J., Pischon, T., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-1062 · Cited by 100
Proteolysis of Insulin-Like Growth Factors (IGF) and IGF Binding Proteins by Cathepsin D
Claussen, M., Kübler, B., Wendland, M., Neifer, K., Schmidt, B., Zapf, J., & Braulke, T. (1997) · Endocrinology · doi:10.1210/endo.138.9.5418 · Cited by 98
Walker, G. E., Wilson, E. M., Powell, D. R., & Oh, Y. (2001) · Endocrinology · doi:10.1210/endo.142.9.8380 · Cited by 98
Self-citationp53 and IGFBP-3: Apoptosis and Cancer Protection
Grimberg, A. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3008 · Cited by 96
Molecular Regulation of Insulin-like Growth Factor-I and Its Principal Binding Protein, IGFBP-3
Phillips, L. S., Pao, C., & Villafuerte, B. C. (1998) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60894-6 · Cited by 94
Marzullo, P., Somma, C. D., Pratt, K. L., Khosravi, J. M., Diamandis, A., Lombardi, G., Colao, A. A. L., & Rosenfeld, R. G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7628 · Cited by 94
Krishnan, A. V., Moreno, J., Nonn, L., Malloy, P. J., Swami, S., Peng, L., Peehl, D. M., & Feldman, D. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.051 · Cited by 92
Self-citationChen, C., Lewis, S. K., Voigt, L. F., Fitzpatrick, A. L., Plymate, S. R., & Weiss, N. S. (2004) · Cancer · doi:10.1002/cncr.20727 · Cited by 91
Nickerson, T., & Huynh, H. T. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600223 · Cited by 86
Butt, A. J., Fraley, K. A., Firth, S. M., & Baxter, R. C. (2002) · Endocrinology · doi:10.1210/endo.143.7.8876 · Cited by 86
Yateman, M., Dc, C., Hughes, S. C. C., Frost, V. J., Wass, J. A. H., & Holly, J. M. P. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1370151 · Cited by 86
Martin, J. L., Weenink, S. M., & Baxter, R. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210739200 · Cited by 81
Sugumar, A., Liu, Y., Xia, Q., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20253 · Cited by 81
Olney, R. C., Wilson, D. M., Mohtai, M., Fielder, P. J., & Smith, R. L. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1460279 · Cited by 81
Rajah, R., Lee, K., & Cohen, P. (2002) · PubMed · Cited by 81
Schedlich, L. J., O’Han, M. K., Leong, G. M., & Baxter, R. C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.049 · Cited by 79
Schernhammer, E. S., Hankinson, S. E., Hunter, D. J., Blouin, M., & Pollak, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11358 · Cited by 75
Tamimi, R. M., Cox, D. G., Kraft, P. L., Pollak, M., Haiman, C. A., Cheng, I. C., Freedman, M. L., Hankinson, S. E., Hunter, D. J., & Colditz, G. A. (2007) · Breast Cancer Research · doi:10.1186/bcr1655 · Cited by 73
Chang, Y. S., Wang, L., Suh, Y., Mao, L., Karpen, S. J., Khuri, F. R., Hong, W. K., & Lee, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207882 · Cited by 73
Aberrant promoter methylation of insulin‐like growth factor binding protein‐3 gene in human cancers
Tomii, K., Tsukuda, K., Toyooka, S., Dote, H., Hanafusa, T., Asano, H., Naitou, M., Doihara, H., Kishimoto, T., Katayama, H., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22341 · Cited by 72
Williams, A. C., Smartt, H., H-Zadeh, A., MacFarlane, M., Paraskeva, C., & Collard, T. J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401919 · Cited by 72
Insulin-like growth factors and subsequent risk of mortality in the United States
Saydah, S., Graubard, B., Ballard-Barbash, R., & Berrigan, D. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm124 · Cited by 71
Thelen, P., Schweyer, S., Hemmerlein, B., Wuttke, W., Seseke, F., & Ringert, R.-H. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.1.25 · Cited by 71
Marzullo, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.3001 · Cited by 71
Wraight, C. J., Venables, I., White, P. J., Hibbs, A. R., & Werther, G. A. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00258.x · Cited by 69
Olivecrona, H., Hilding, A., Ekström, C., Barle, H., Nyberg, B., Möller, C., Delhanty, P. J. D., Baxter, R. C., Angelin, B., Ekström, T. J., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5466 · Cited by 69
Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse.
Domené, H. M., Bengolea, S. V., Jasper, H., & Boisclair, Y. R. (2005) · PubMed · Cited by 68
Singh, B., Charkowicz, D., & Mascarenhas, D. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307322200 · Cited by 67
Promotion of Cancer Cell Migration
Fu, P., Thompson, J. A., & Bach, L. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703066200 · Cited by 63
Gibson, T. L. B., & Cohen, P. (1999) · Growth Hormone & IGF Research · doi:10.1054/ghir.1999.0115 · Cited by 62
Dawson, M., Hobbs, P. D., Peterson, V. J., Leid, M. E., Lange, C. W., Feng, K. C., Chen, G.-Q., Gu, J., Li, H., Kolluri, S. K., et al. (2001) · PubMed · Cited by 61
Fuchs, C. S., Goldberg, R. M., Sargent, D. J., Meyerhardt, J. A., Wolpin, B. M., Green, E. M., Pitot, H. C., & Pollak, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0480 · Cited by 60
Cheng, I. C., Henderson, K. D., Haiman, C. A., Kolonel, L. N., Henderson, B. E., Freedman, M. L., & Marchand, L. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0790 · Cited by 59
Oufattole, M., Lin, S. W.-J., Liu, B., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1269 · Cited by 57
Insulin‐like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma
Benini, S., Zuntini, M., Manara, M. C., Cohen, P., Nicoletti, G., Nanni, P., Oh, Y., Picci, P., & Scotlandi, K. (2006) · International Journal of Cancer · doi:10.1002/ijc.21929 · Cited by 57
Self-citationWeiss, J. M., Huang, W., Rinaldi, S., Fears, T. R., Chatterjee, N., Chia, D., Crawford, E. D., Kaaks, R., & Hayes, R. B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22921 · Cited by 56
Liao, L., Dearth, R. K., Zhou, S., Britton, O. L., Lee, A. V., & Xu, J. (2006) · Endocrinology · doi:10.1210/en.2005-1537 · Cited by 56
Butt, A. J., Dickson, K. A., Jambazov, S., & Baxter, R. C. (2005) · Endocrinology · doi:10.1210/en.2004-1408 · Cited by 55
Grimberg, A., Coleman, C. M., Burns, T. F., Himelstein, B. P., Koch, C. J., Cohen, P., & El‐Deiry, W. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1213 · Cited by 55
Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog
Zhang, Y., Dawson, M. I., Mohammad, R. M., Rishi, A. K., Farhana, L., Feng, K.-C., Leid, M. E., Peterson, V. J., Zhang, X.-K., Edelstein, M., et al. (2002) · Blood · doi:10.1182/blood.v100.8.2917 · Cited by 53
Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3
Campbell, P. G., Durham, S. K., Suwanichkul, A., Hayes, J. D., & Powell, D. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.2.e321 · Cited by 49
Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3
Lee, K., Cobb, L. J., Paharkova, V., Liu, B., Milbrandt, J., & Cohen, P. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm088 · Cited by 47
Cobb, L. J., Liu, B., Lee, K., & Cohen, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0585 · Cited by 47
Sala, A., Capaldi, S., Campagnoli, M., Faggion, B., Labò, S., Perduca, M., Romano, A., Carrizo, M. E., Valli, M., Visai, L., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504304200 · Cited by 45
Yi, H., Kim, S., Hwang, P., Kim, C. Y., Yang, D.-H., Oh, Y., & Lee, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.045 · Cited by 44
Self-citationArosio, M., Garrone, S., Bruzzi, P., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7288 · Cited by 43
Mishra, S., Raz, A., & Murphy, L. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2877 · Cited by 38
Becker, S., & Kaaks, R. (2008) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-69297-3_14 · Cited by 36
Peng, L., Wang, J., Malloy, P. J., & Feldman, D. (2007) · International Journal of Cancer · doi:10.1002/ijc.23100 · Cited by 36
Self-citationDevi, G. R., Yang, D.-H., Rosenfeld, R. G., & Oh, Y. (2000) · Endocrinology · doi:10.1210/endo.141.11.7781 · Cited by 35
Self-citationTsubaki, J., Choi, W., Ingermann, A., Twigg, S., Kim, H., Rosenfeld, R. G., & Oh, Y. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690097 · Cited by 34
Self-citationPeng, L., Malloy, P. J., Wang, J., & Feldman, D. (2006) · Endocrinology · doi:10.1210/en.2006-0560 · Cited by 31
Self-citationKuang, Z., Yao, S., McNeil, K. A., Thompson, J. A., Bach, L. A., Forbes, B. E., Wallace, J. C., & Norton, R. S. (2007) · Biochemistry · doi:10.1021/bi701251d · Cited by 26
Berrigan, D. A., Potischman, N. A., Dodd, K. W., Nicar, M. J., McQuillan, G. M., Lavigne, J. A., Barrett, J. C., & Ballard-Barbash, R. R. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0044 · Cited by 26
Arosio, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1091 · Cited by 25
Blum, W. F. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511549304.004 · Cited by 22
CDX2 promotes anchorage-independent growth by transcriptional repression of IGFBP-3
Chun, S. Y., Chen, F., Washburn, J. G., MacDonald, J. W., Innes, K. L., Zhao, R., Cruz-Correa, M. R., Dang, L. H., & Dang, D. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210258 · Cited by 22
Zappalà, G., Elbi, C., Edwards, J., Gorenstein, J., Rechler, M. M., & Bhattacharyya, N. (2007) · Endocrinology · doi:10.1210/en.2007-1315 · Cited by 21
Mishra, S., & Murphy, L. J. (2003) · Endocrinology · doi:10.1210/en.2003-0089 · Cited by 18
Cited by
Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy
Yoshida, T., & Delafontaine, P. (2020) · Cells · doi:10.3390/cells9091970 · Cited by 714
IGF binding proteins in cancer: mechanistic and clinical insights
Baxter, R. C. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3720 · Cited by 525
The role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500
Duan, C., Ren, H., & Gao, S. (2010) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2010.04.009 · Cited by 492
Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D
Krishnan, A. V., & Feldman, D. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100611 · Cited by 470
Self-citation
Metadata
- Authors
- Jogie-Brahim, S., Feldman, D., & Oh, Y.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2009-05-28
- Volume
- 30
- Issue
- 5
- Pages
- 417-437
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2011369409
- Cited by
- 323
- References
- 186
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.